Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Richard Aldrich

Affiliations

  • Director at Concert Pharmaceuticals Inc. (CNCE), 2019-06-18
  • Director at Millendo Therapeutics Inc. (MLND), 2018-12-12
  • Director at Kalvista Pharmaceuticals Inc. (KALV), 2018-10-05
  • Director at Ptc Therapeutics Inc. (PTCT), 2015-06-10
  • Director at Verastem Inc. (VSTM), 2014-06-11
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
CNCE $11.78 40,000 Director 336,975 2018-11-15 Filing
CNCE $12.00 10,000 Director 296,975 2018-11-15 Filing
KALV $8.61 565,065 Director 934,484 2017-10-12 Filing
OVAS $7.00 425,000 Director 962,056 2016-06-01 Filing
OVAS $7.86 20,000 Director 537,056 2016-05-18 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
CNCE $19.99 1,946 Director 0 2018-02-01 Filing
CNCE $21.29 300 Director 1,946 2018-01-31 Filing
CNCE $20.78 4,700 Director 2,246 2018-01-31 Filing
CNCE $21.33 5,000 Director 6,946 2018-01-30 Filing
CNCE $21.36 5,000 Director 11,946 2018-01-29 Filing